David Altshuler

2016

In 2016, David Altshuler earned a total compensation of $4.8M as EVP & Chief Scientific Officer at Vertex Pharmaceuticals, a 61% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$500,250
Option Awards$1,087,620
Salary$561,442
Stock Awards$2,625,152
Other$12,885
Total$4,787,349

Altshuler received $2.6M in stock awards, accounting for 55% of the total pay in 2016.

Altshuler also received $500.3K in non-equity incentive plan, $1.1M in option awards, $561.4K in salary and $12.9K in other compensation.

Rankings

In 2016, David Altshuler's compensation ranked 1,719th out of 14,075 executives tracked by ExecPay. In other words, Altshuler earned more than 87.8% of executives.

ClassificationRankingPercentile
All
1,719
out of 14,075
88th
Division
Manufacturing
586
out of 5,489
89th
Major group
Chemicals And Allied Products
163
out of 1,895
91st
Industry group
Drugs
112
out of 1,538
93rd
Industry
Pharmaceutical Preparations
88
out of 1,176
93rd
Source: SEC filing on April 28, 2017.

Altshuler's colleagues

We found five more compensation records of executives who worked with David Altshuler at Vertex Pharmaceuticals in 2016.

2016

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2016

Michael Parini

Vertex Pharmaceuticals

EVP & Chief Legal and Administrative Officer

2016

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2016

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2016

Amit Sachdev

Vertex Pharmaceuticals

EVP & Chief Regulatory Officer

You may also like